Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET
Company Participants
Doug Murphy-Chutorian – CEO
Eric Semler – Chairman
Jennifer Oliva Herrington – COO
Renae Cormier – CFO
Operator
Good afternoon, and welcome to the Semler Scientific’s Fourth Quarter and Full Year 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded.
Before we begin, Semler Scientific’s needs to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include statements regarding the expectations for expansion of the business and development and marketing of additional products, including receipt and timing of an additional 510(k) clearance from QuantaFlo and our Bitcoin treasury strategy and plans to acquire additional Bitcoin. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements.
Those risks and uncertainties are described in the press release and our SEC filings. The forward-looking statements made today are as of the date of this call, and the company does not undertake any obligation to update the forward-looking statements. If you do not have a copy of today’s press release, you may obtain one by visiting the Investor Relations page of the website, semlerscientific.com.
I would now like to introduce Dr. Doug Murphy-Chutorian, CEO of Semler Scientific. Please go ahead, sir.
Doug Murphy-Chutorian
Good afternoon, everyone, and thank you for joining us for 2024 fourth quarter and full year results call. Once again, we achieved strong performance and cash generation from our health care operations. And in 2024, we deployed much of this cash and the
Read the full article here